SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-18-019195
Filing Date
2018-11-01
Accepted
2018-10-31 19:33:06
Documents
4
Period of Report
2018-10-31
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K snbp20181031_8k.htm 8-K 27457
2 EXHIBIT 10.1 ex_127268.htm EX-10.1 29780
3 EXHIBIT 99.1 ex_127234.htm EX-99.1 12593
4 logo.jpg GRAPHIC 10564
  Complete submission text file 0001437749-18-019195.txt   85911
Mailing Address 712 VISTA BLVD #305 WACONIA MN 55387
Business Address 712 VISTA BLVD #305 WACONIA MN 55387 9524791196
Sun BioPharma, Inc. (Filer) CIK: 0001029125 (see all company filings)

IRS No.: 870543922 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55242 | Film No.: 181151547
SIC: 2834 Pharmaceutical Preparations